David Hinkle

David has served as Vice President, Finance and Controller of Boundless Bio since June 2021. He has a wealth of financial and technical accounting knowledge and experience stemming from over 25 years in the industry. Prior to Boundless, David served as Vice President, Finance and Controller at Crinetics Pharmaceuticals, where he was responsible for developing and leading their accounting team subsequent to their initial public offering in July 2018. During his tenure at Crinetics, he provided instrumental support of fund raising activities, helping to generate more than $350 million to finance the expansion of discovery, development and clinical trial activities. Prior to Crinetics, David served in similar capacities at Ignyta, Receptos, Somaxon Pharmaceuticals and Digirad, where he was responsible for accounting operations. David began his career at Deloitte. He earned a B.S. degree from California State University, Northridge and is a Certified Public Accountant (inactive status) in California.